Viewing Study NCT04397003


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2025-12-30 @ 1:40 PM
Study NCT ID: NCT04397003
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-22
First Post: 2020-05-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer
Sponsor: Washington University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module